Matt Parkes

Matt Parkes

mattyjparkes.bsky.social

Statistician. Interests: clinical trials methods, psychology, MSK medicine, rheumatology, oncology, chronic pain, adaptive trials, outcomes, digital health/wearables, Open Research, Stata, R, and code ligatures. https://orcid.org/0000-0002-1574-9933

👤 Joined on 13 November 2023

498

Followers

625

Following

328

Total Posts

📜 Kullanıcı Geçmişi

  • 13 Kas 2023, 10:25
    🎉 Bluesky'e katıldı - İlk kullanıcı adı: @mattyjparkes.bsky.social
  • 13 Kas 2023, 16:51
    🔄 Profil bilgileri güncellendi

❤️ Beğendiği Gönderiler

Well, congratulations Triple D, you made me read the bloody Lancet paper, a more suitable but less sexy headline would be: AI analysis of facial photographs identifies differences in survival among patients receiving radiotherapy. I'm going to vibe code a headline re-writer.

Show Post
Darren Dahly
20 October 2026 09:58

This is going straight into my "social media impact" folder.

Show Post

I heard story on radio this morning and I made a small wager with myself: I bet Dr Darren Dahly (triple D as I am now calling you) will be enraged by this enough to share it. Result. A free coffee! wait...

Show Post
Darren Dahly
15 October 2026 17:12

Most systematic reviews and meta- analyses now include some assessment of study quality but these don't usually impact a review's conclusions. It's typically just some tick boxes or traffic lights and vague qualitative statements. We should instead filter out poor studies. What is wrong with us?

Show Post

But if one has looked at studies and decided their quality was too low to be included, that fact and a brief reason why are useful: a) To avoid reader wondering if such studies were overlooked. b) To help reader ignore them. c) To help reader assess the quality of the author(s)' judgment.

Show Post

Select language

Install App

Install App